Transferrin Saturation Calculator

🩸 Transferrin Saturation (TSAT) Calculator

Assess iron status for deficiency and overload conditions.


Transferrin Saturation (TSAT)

%

0% 20% 50% 75%+
Show calculation steps

Recent Updates

  • In CKD-related anemia, KDIGO 2026 anemia guidance frames iron therapy around TSAT and ferritin (e.g., considering IV iron when TSAT ≤30% with ferritin ≤500 ng/mL, and reassessing when TSAT is >40% or ferritin >700 ng/mL).
  • In heart failure, iron deficiency is defined functionally (ferritin <100 ng/mL, or ferritin 100–299 ng/mL with TSAT <20%); 2021/2023 ESC guidance supports IV iron repletion in this setting.
  • For hereditary hemochromatosis screening, current hepatology guidance uses a fasting TSAT threshold of >45% — lower than this tool’s >50% overload band.

Sources: KDIGO 2026 Anemia in CKD (PMID 41485812) · 2023 ESC HF focused update (PMID 37622666) · EASL 2022 haemochromatosis (PMID 35662478)

Key Knowledge Points

  • Transferrin Saturation (TSAT) represents the percentage of transferrin, the body’s main iron transport protein, that is saturated with iron.
  • A low TSAT (typically <20%) is a primary and early indicator of iron deficiency, often appearing before hemoglobin levels drop.
  • A high TSAT (>50%) is a key indicator for investigating iron overload states, such as hereditary hemochromatosis.
  • TSAT should always be interpreted in the context of other iron studies, especially serum ferritin (iron stores), and the patient’s clinical condition.

About This Transferrin Saturation Calculator

This Transferrin Saturation Calculator is a clinical tool designed to quickly compute TSAT, a critical marker in the assessment of iron metabolism. By entering the serum iron and Total Iron-Binding Capacity (TIBC), clinicians can efficiently evaluate a patient’s current iron status, aiding in the diagnosis and management of conditions like iron deficiency anemia and iron overload diseases.

The Formula Explained

Transferrin Saturation is calculated as the ratio of serum iron to the total iron-binding capacity, expressed as a percentage. This reflects how much of the iron-transporting protein (transferrin) is actually carrying iron.

$$ \text{TSAT (\%)} = \frac{\text{Serum Iron (mcg/dL)}}{\text{TIBC (mcg/dL)}} \times 100 $$

Clinical Interpretation & Limitations

The calculated TSAT value is interpreted within established clinical ranges:

  • Low Saturation (<20%): Suggestive of iron deficiency. It indicates insufficient iron is available for red blood cell production.
  • Normal Saturation (20% – 50%): Reflects adequate iron availability for metabolic needs.
  • High Saturation (>50%): Suggests iron overload. A persistently high TSAT is a strong reason to investigate hereditary hemochromatosis. For hemochromatosis screening, guidelines use a lower fasting TSAT cut-off of >45%; this calculator’s >50% band flags more pronounced overload.

Limitations

TSAT values can be influenced by several factors. Serum iron has a significant diurnal variation (highest in the morning), so a morning, preferably fasting sample is preferred for consistency. Inflammation (as seen in infection or chronic disease) can decrease both serum iron and TIBC, sometimes yielding a falsely “normal” TSAT despite functional iron deficiency — iron that is present but unavailable for red-cell production. Therefore, results must always be correlated with the patient’s full clinical picture and other tests such as ferritin (and, where available, an inflammatory marker like CRP). Because TSAT is a ratio, it is unaffected by the reporting unit (mcg/dL vs SI µmol/L) as long as iron and TIBC are expressed in the same unit.

Special Clinical Contexts

Heart failure: Iron deficiency is common and is defined functionally as ferritin <100 ng/mL, or ferritin 100–299 ng/mL together with TSAT <20%. In symptomatic patients meeting these criteria, ESC guidance supports intravenous iron repletion to improve symptoms and reduce heart-failure hospitalizations.

Chronic kidney disease: TSAT and ferritin together guide iron therapy in CKD-related anemia. KDIGO 2026 anemia guidance frames decisions around these markers — for example, considering iron when TSAT is ≤30% with ferritin ≤500 ng/mL, and re-evaluating when TSAT exceeds ~40% or ferritin exceeds ~700 ng/mL.

Hemochromatosis: A persistently elevated fasting TSAT (>45%) is the key biochemical screen for hereditary hemochromatosis and should prompt ferritin measurement and, where appropriate, HFE genotyping.

Frequently Asked Questions (FAQ)

1. What is the difference between Ferritin and TSAT?

Ferritin reflects the body’s iron stores (“savings account”), while TSAT reflects iron currently in transport for use (“cash in wallet”). A low TSAT indicates not enough iron is available for immediate use, while a low ferritin means the body’s reserves are depleted. They are often measured together.

2. Why is a fasting, morning sample preferred?

Serum iron levels fluctuate throughout the day and are affected by recent iron intake from food. A fasting, morning blood draw provides a standardized baseline, making the results more reliable and comparable over time.

3. What is TIBC (Total Iron-Binding Capacity)?

TIBC is an indirect measurement of transferrin. When the body is iron-deficient, it produces more transferrin to try and capture more iron, leading to a high TIBC. Conversely, in iron overload, transferrin levels drop, leading to a low TIBC.

4. Can I have iron deficiency with a normal TSAT?

It’s less common, but possible. For example, in the “anemia of chronic disease/inflammation,” inflammation can lower TIBC, which might keep the TSAT ratio in the normal range even if iron stores (ferritin) are low or functionally unavailable.

5. Does a high TSAT always mean I have hemochromatosis?

Not necessarily. While a persistently high TSAT is a key screening indicator for hereditary hemochromatosis, it can also be elevated in other conditions like liver disease or from multiple blood transfusions. Further investigation is required.

⚠️ Disclaimer:

This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.